C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2006
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	US20060264419 Substituted pyrazoles
11/23/2006	US20060264390 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/23/2006	DE102005021963A1 New substituted dihydropyrazolotriazinone compounds, useful for treating bacterial diseases/infections
11/23/2006	CA2609299A1 Raf inhibitor compounds and methods of use thereof
11/23/2006	CA2608974A1 Substituted 7,8-dihydro-1h-pyrimido[4,5-b][1,4]diazepin-4-amines are novel kinase inhibitors
11/23/2006	CA2608718A1 1, 2, 4-triazole derivatives as vasopressin antagonists
11/23/2006	CA2608490A1 Preparation of famciclovir and other purine derivatives
11/23/2006	CA2608240A1 Multicyclic compounds and methods of their use
11/23/2006	CA2607883A1 Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor (fsh-r) antagonists
11/23/2006	CA2607882A1 Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (fsh-r) antagonists
11/23/2006	CA2605050A1 Histone deacetylase inhibitors
11/22/2006	EP1724295A1 Supramolecular complex of pyridylnaphthalenediimide with zinc porphyrin dendrimer having multiplicity of artificial photosynthetic reaction center
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1724261A1 Photocharge separation using supramolecular complex of pi-electron type extended viologen derivative and porphyrin
11/22/2006	EP1723152A1 Pyrrolobenzodiazepines
11/22/2006	EP1723151A2 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines
11/22/2006	EP1723147A1 Process for inhibiting cell proliferation
11/22/2006	EP1723146A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
11/22/2006	EP1723144A1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/22/2006	EP1722826A2 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses
11/22/2006	EP1532210B1 Rylene dyes
11/22/2006	EP1530574B1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments
11/22/2006	EP1483265B1 Purine derivatives as kinase inhibitors
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	CN1867569A 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents
11/22/2006	CN1865244A Synthesis method of imide substituted bridge ring compound
11/22/2006	CN1864822A Separating film for removing carbon monoxide, separating film assembly, method of removing carbon monoxide from an oxygen carrier and apparatus for removing carbon monoxide, oxygen carrier and its pha
11/22/2006	CN1285605C Antitumour indolo pyrrolo carbazole derivatives
11/22/2006	CN1285594C Oxytocin agonists
11/22/2006	CN1285593C Pyrrolopyridazine compound
11/21/2006	US7139418 Fluoroscopic registration artifact with optical and/or magnetic markers
11/21/2006	US7138526 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
11/21/2006	US7138521 Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor
11/21/2006	US7138402 Pyrrolopyrimidines and related analogs as HSP90-inhibitors
11/21/2006	US7138401 9-(Substituted phenyl or pyridyl)methyl-2-amino-6-halopurines, e.g., 6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine; used in the treatment and prevention of various Heat Shock Protein 90 mediated disorders, e.g., proliferative disorders
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	US7138395 Interleukin-1β converting enzyme inhibitors
11/21/2006	US7138393 Biologically active vasopressin agonist metabolites
11/21/2006	US7138377 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
11/21/2006	CA2120619C Novel potent inducers of terminal differentiation and methods of use thereof
11/16/2006	WO2006122011A2 Thiazole compounds and methods of use
11/16/2006	WO2006121191A1 Porphyrin-based electrode catalyst
11/16/2006	WO2006120573A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/16/2006	WO2006120552A2 ANHYDROUS CRYSTALLINE FORMS OF N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINO)-7-(4-METHYLPYRIDIN-2-yl-AMINO)-1H-PYRAZOLO[4,3-d]PYRIMIDINE-3-CARBONYL]METHANESULFONAMIDE
11/16/2006	WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	WO2006119713A2 Antineoplastic compounds and pharmaceutical compositions thereof
11/16/2006	WO2006002895A3 Conjugates of antibody and duoarmycin derivatives as antitumor agents
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006	US20060258879 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
11/16/2006	US20060258865 Reacting an acid addition salt of D-Tryptophan methyl ester with piperonal in the presence of high boiling solvent wherein high boiling solvent is selected from N,N-Dimethyl acetamide, Dimethyl sulfoxide, N,N-dimethyl formamide, N-methyl pyrrolidine or mixture thereof and in presence of dehydrating agent
11/16/2006	US20060258858 Coordination complex system comprising building blocks
11/16/2006	US20060258710 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
11/16/2006	US20060258695 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
11/16/2006	US20060258690 Spiro-substituted pyrrologyrimidines
11/16/2006	US20060258689 Fused heterocyclic compounds, and compositions and uses thereof
11/16/2006	US20060258687 Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
11/16/2006	US20060258685 Substituted pyrazolopyrimidines, methods for the production thereof, use of the same for controlling pathogenic fungi, and agents containing said compounds
11/16/2006	US20060258665 Bridged ring NK1 antagonists
11/16/2006	US20060258662 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
11/16/2006	US20060258659 Heterocyclic compounds and their uses as therapeutic agents
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258649 Agronomic pesticide; less toxic; 4-imino-4H-3,1-benzoxazines e.g. N-(2-(3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl)-6-chloro-8-methyl-4H-3,1-benzoxazin-4-ylidene)methanamine
11/16/2006	US20060258646 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/16/2006	US20060258645 Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists
11/16/2006	US20060258644 Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor (FSH-R) antagonists
11/16/2006	US20060258643 Gabaergic agents to treat memory deficits
11/16/2006	US20060258641 Methods and compositions of novel triazine compounds
11/16/2006	US20060258637 Fused polycyclic compounds
11/16/2006	US20060258612 CFTR channel modulators
11/16/2006	US20060257329 Delivery of drug esters through an inhalation route
11/16/2006	DE19948436B4 Bicyclische Imidazo-5-aminderivate Bicyclic imidazo-5-amine derivatives
11/16/2006	CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	CA2607617A1 Thiazole compounds and methods of use
11/16/2006	CA2607298A1 Antineoplastic compounds and pharmaceutical compositions thereof
11/16/2006	CA2607021A1 Diaryl-purines, -azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
11/15/2006	EP1720883A1 Pyrazolotriazines as kinase inhibitors
11/15/2006	EP1720882A2 Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
11/15/2006	EP1720881A1 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepins
11/15/2006	EP1720880A1 C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs thereof as well as related compounds for the treatment of proliferative diseases
11/15/2006	EP1720879A2 Azolopyrimidine compounds and use thereof for combating parasitic fungi
11/15/2006	EP1720878A1 Heteroaryl-fused pyrazolo derivatives
11/15/2006	EP1720877A2 Aryl substituted purine analogues
11/15/2006	EP1720857A1 Dihydropyridinone derivatives
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720841A2 Quinazoline derivatives and therapeutic use thereof
11/15/2006	EP1720613A2 Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3
11/15/2006	EP1720545A1 Bicyclic and bridged nitrogen heterocycles
11/15/2006	EP1562945B1 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof
11/15/2006	EP1411881B9 5ht2c receptor modulators
11/15/2006	EP1392692B1 (oxo-pyrazolo¬1,5a\|pyrimidin-2-yl)alkyl-carboxamides
11/15/2006	EP1345942B9 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
11/15/2006	EP1335919B1 Triazolo[4,5-d]pyrimidine derivatives as anti-thrombotic agents
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1244679B1 Purine derivatives

1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 573